Share This Author
Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: A promising in vivo drug delivery system for colorectal cancer therapy.
Prognostic Significance of EDIL3 Expression and Correlation with Mesenchymal Phenotype and Microvessel Density in Lung Adenocarcinoma
- D. Jeong, Seona Ban, Seunghyun Oh, Su Jin Lee, Seong Yong Park, Y. Koh
- Medicine, BiologyScientific Reports
- 17 August 2017
EDIL3 is significantly correlated with mesenchymal phenotype, angiogenesis, and tumor progression in lung adenocarcinoma and was an independent prognostic factor for overall survival in a multivariate analysis.
Karyopherin α-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer
- D. Jeong, Hyeongjoo Kim, M. Baek
- Medicine, BiologyJournal of Cancer Research and Clinical Oncology
- 5 September 2017
KPNA2 expression is useful for identification of patients with high-risk stage II CRC who could benefit from AC and that KPNA2 may also be a promising therapeutic target.
Protein kinase, membrane‑associated tyrosine/threonine 1 is associated with the progression of colorectal cancer.
The protein kinase, membrane‑associated tyrosine/threonine 1 (PKMYT1) is known to inhibit precocious entry into mitosis by phosphorylating CDK1 at Thr14 and Tyr15 residues. However, the functional…
Defensin alpha 6 (DEFA6) is a prognostic marker in colorectal cancer.
It is revealed that DEFA6 is associated with overall survival rate of CRC patients and thus an independent prognostic marker for CRC and serves a good therapeutic target for the disease.
Abstract 709:In vitrofunctional study of novel oncogene serine protease 33 (PRSS33) and the clinical significance of PRSS33 expression in colorectal cancer patients
This study indicates that PRSS33 is a novel pro-oncogene and the expression is an independent prognostic factor in colorectal cancer patients.
Abstract 4455: Identification of novel oncogene, copine-7 (CPNE7), in colorectal cancer
It is announced that CPNE7 is a novel oncogene, an independent prognostic factor and therapeutic target in colorectal cancer.